Evidence map›Paper›PMID 39460296›Full record

ArticleVaccines2024

Linda Voogd, Marjolein van Wolfswinkel, Iman Satti, Andrew D White, Karin Dijkman, Anele Gela, Krista E van Meijgaarden, Kees L M C Franken, Julia L Marshall, Tom H M Ottenhoff and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. HLA-E/Frontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

15 authors.

Linda VoogdLeiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-0523-8929
Marjolein van WolfswinkelLeiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-4952-9709
Iman SattiThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Andrew D WhiteUK Health Security Agency, Porton Down, Wiltshire SP4 0JG, UK.ORCID 0000-0001-9481-0079
Karin DijkmanBiomedical Primate Research Centre, 2288 GJ Rijswijk, The Netherlands.
Anele GelaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0003-1473-9204
Krista E van MeijgaardenLeiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-2818-9805
Kees L M C FrankenLeiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Julia L MarshallThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Tom H M OttenhoffLeiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
Helen McShaneThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-2126-5142
Sally A SharpeUK Health Security Agency, Porton Down, Wiltshire SP4 0JG, UK.ORCID 0000-0002-7014-7660
Frank A W VerreckBiomedical Primate Research Centre, 2288 GJ Rijswijk, The Netherlands.ORCID 0000-0002-4441-5000
Simone A JoostenLeiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-9878-0863

Funding

HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infectionR01AI141315 · NIAID · LEIDEN UNIVERSITY MEDICAL CENTER · PI JOOSTEN, SIMONE ANNE · 2019 to 2022
$1.7M
National Institute of Health R01AI141315NIAID NIH HHS R01 AI141315
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCGHLA-ET cellstuberculosisvaccine

Identifiers

PMID39460296
PMCPMC11511431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.